NCT05800834 2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
Instituto Nacional de Cancer, Brazil
Sichuan Cancer Hospital and Research Institute
NWTraumatherapies
Georgetown University
Mansoura University
Jiangxi Provincial Cancer Hospital
National Taiwan University Hospital